Compounds for the treatment of mycobacterial infections
USRE48105E1 · kind E1 · reissue
0Cited by
3References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 14, 2018 |
| Grant date | Jul 21, 2020 |
| Priority date | — |
| Expiry date | Aug 14, 2038 |
Classification
- Technology area (CPC —)General
Abstract
The invention relates to compounds of Formula I or a pharmaceutically acceptable salt, ester or prodrug thereof:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.